Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
The Hastings Center Report|December 14, 2021
Deliberative Public Consultation via Deliberative Polling: Criteria and MethodsJames S FishkinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032James N Ingle, Vera J Suman, Kendrith M Rowland, et al.Clinical Breast Cancer|March 27, 2012
Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trialWinston W Tan, Jacob B Allred, Muhammad Salim, et al.Cancer|May 13, 2008
Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment GroupDavid J Inwards, Paul A S Fishkin, David W Hillman, et al.Haematologica|July 29, 2021
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomasAjay Major, Justin Kline, Theodore G Karrison, et al.Medical Oncology (Northwood, London, England)|August 24, 2010
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junctionNicholas W Choong, Ann M Mauer, Daniel C Haraf, et al.Blood Advances|July 28, 2025
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCLKirk E Cahill, James K Godfrey, Chadi Nabhan, et al.Pageof 1